NCT05819541View on ClinicalTrials.gov

Treating Exacerbations of Asthma With Oral Montelukast in Children

PHASE2RecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

October 20, 2023

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Status Asthmaticus
Interventions
DRUG

Montelukast Oral Granules

Oral montelukast granules, USP powder, or crushed tablets at weight-based doses between 2 mg/kg and 3 mg/kg to a maximum of 180 mg.

DRUG

Albuterol

Inhaled albuterol by metered-dose inhaler (MDI) or nebulizer

DRUG

Corticosteroid

Oral or parenteral corticosteroid (e.g., dexamethasone, methylprednisolone)

Trial Locations (1)

37232-9001

RECRUITING

Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville

All Listed Sponsors
lead

Vanderbilt University Medical Center

OTHER